Ignacio Ricci-CabelloAdrián Vásquez-MejíaCarlos Canelo-AybarEna Niño de GuzmanPerez, JavierJavierPerezMontserrat RabassaDavid RigauIvan SolàYang SongLuciana NeamtiuElena ParmelliZuleika Saz-ParkinsonPablo Alonso-Coello2025-04-142025-04-142020-10-0710.1186/s12913-020-05753-xhttps://cris-uv.scimago.es/handle/123456789/2306WOS:000578522000003Breast cancer (BC) clinical guidelines offer evidence-based recommendations to improve quality of healthcare for patients with or at risk of BC. Suboptimal adherence to recommendations has the potential to negatively affect population health. However, no study has systematically reviewed the impact of BC guideline adherence -as prognosis factor- on BC healthcare processes and health outcomes. The objectives are to analyse the impact of guideline adherence on health outcomes and on healthcare costs.acceso abiertoHEALTH CARE SCIENCES SERVICESjournal-article